Parenthood and immunomodulation in patients with multiple sclerosis.
about
Pregnancy, sex and hormonal factors in multiple sclerosis.A review of safety-related pregnancy data surrounding the oral disease-modifying drugs for multiple sclerosis.Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancyDisease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.Sex and gender issues in multiple sclerosis.Multiple sclerosis and pregnancy: therapeutic considerations.Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.Evaluating the Safety of Medication Exposures During Pregnancy: A Case Study of Study Designs and Data Sources in Multiple Sclerosis.Multiple sclerosis in men: management considerations.Treatment of multiple sclerosis during pregnancy - safety considerations.Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application.Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry.Glatiramer acetate during early pregnancy: A prospective cohort study.Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment.Birth outcomes in newborns fathered by men with multiple sclerosis exposed to disease-modifying drugs.
P2860
Q30354175-8A03F7E7-BA0C-4B48-9744-410ADFB7AA4EQ30716854-135DA014-D0D8-4758-BC42-3F305CC248FDQ31162052-C8BCD537-FE1B-4E8E-8CF4-203A33596118Q36298897-9F7BED5B-4553-4C26-8FF5-0324851FC648Q36475245-1492E39C-75BC-4F09-BE52-CDC87986C607Q36999743-BE3BE21D-7FA7-445B-A008-C7142BCEF69AQ38038437-4428A04C-14DD-4C64-AB70-F9481478E66FQ38085336-439A63AA-05F5-4325-BFB1-129CE6D0FA96Q38125249-DC61F3B4-0723-40A8-BDCE-DCCB7266A79AQ38379249-56ACAB90-46C8-4D27-9DD9-E18948AC4EE0Q38653267-B3EFC38B-DB91-413B-8935-BBD7CCB88552Q38685411-5277E1D3-5E35-4932-BC78-FC9F114A8EBFQ38883520-67ED1846-4FFE-4201-AB30-A6E698D88870Q38921991-7438771A-14CB-417A-8A60-9B660498DEE3Q39964998-BFA7C7D8-B524-49A8-81A8-46A1B11911ABQ40120131-5731E396-4312-4B7F-9E31-4B3749DAFCF7Q46189424-3995F78C-A760-40B6-919A-8B58A4E30186Q48543545-F72F96EB-9710-4A3D-8F15-03B5C6B00042
P2860
Parenthood and immunomodulation in patients with multiple sclerosis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Parenthood and immunomodulation in patients with multiple sclerosis.
@en
Parenthood and immunomodulation in patients with multiple sclerosis.
@nl
type
label
Parenthood and immunomodulation in patients with multiple sclerosis.
@en
Parenthood and immunomodulation in patients with multiple sclerosis.
@nl
prefLabel
Parenthood and immunomodulation in patients with multiple sclerosis.
@en
Parenthood and immunomodulation in patients with multiple sclerosis.
@nl
P2093
P1433
P1476
Parenthood and immunomodulation in patients with multiple sclerosis.
@en
P2093
Aiden Haghikia
Kerstin Hellwig
P2888
P304
P356
10.1007/S00415-009-5376-Z
P577
2009-11-21T00:00:00Z